Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P206. Is the IBD pre-endoscopic screening F-Calprotectin test more cost-effective than the usage of serologic markers in selected European markets?
Authors:

B. Mascialino1, L.-L. Hermansson2, A. Larsson3, 1Thermo Fisher Scientific, Phadia AB, Uppsala, Sweden, 2Thermo Fisher Scentific, Phadia AB, Uppsala, Sweden, 3Uppsala University, Department of Medical Science, Uppsala, Sweden

P206. The influence of 5-ASA on thiopurines in Chinese IBD therapy
P206

Prevalence and risk factors for thromboembolic complications in IBD patients

Authors:

A. Schoepfer*1, A. Alatri2, N. Fournier3, 4, E. Safroneeva5, L. Calanca2, L. Mazzolai2

1Centre Hospitalier Universitaire Vaudois, Gastroenterology and Hepatology, Lausanne, Switzerland, 2Centre Hospitalier Universitaire Vaudois, Angiology, Lausanne, Switzerland, 3Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 4University of Lausanne, IUMSP, Lausanne, Switzerland, 5University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland

P207.

Indeterminate and inconclusive results are common when using interferon gamma release assay as screening for TB in patients with IBD

Authors:

I. Nasr, R. Goel, M. Ward, S. Fong, K. Patel, M. Sastrillo, S. Anderson, J. Sanderson, P. Irving, Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

P207. Is medical treatment a risk factor for adverse birth outcomes among women with Crohn's disease?
Authors:

M. Julsgaard1, M. Nørgaard2, C.L. Hvas1, A. Grosen1, S. Hasseriis2, L.A. Christensen1, 1Aarhus University Hospital, Department of Medicine V, (Gastroenterology and Hepatology), Aarhus C, Denmark, 2Aarhus University Hospital, Department of Clinical Epidemiology, Aarhus C, Denmark

P207. One-year response and remission rates in ulcerative colitis patients with week 8 response to adalimumab: Subanalysis of ULTRA 2
P207. Oral tacrolimus therapy is useful for patients with intractable ulcerative colitis: A result of post-marketing analysis
P207

Serological Antibodies for the Prediction of Post-operative Recurrent Crohn's Disease. Results from the POCER study

Authors:

A.L. Hamilton*1, M.A. Kamm2, F. Selvaraj3, F. Princen3, P. De Cruz2, E.K. Wright2, K.J. Ritchie2, E.O. Krejany1, A. Gorelik2, D. Liew2, L. Prideaux2, I.C. Lawrance2, J.M. Andrews2, P.A. Bampton2, M. Sparrow2, T.H. Florin2, P.R. Gibson2, H. Debinski2, R. Gearry2, F.A. Macrae2, R. Leong2, I. Kronborg2, G. Radford-Smith2, W. Selby2, M.J. Johnston2, R. Woods2, P.R. Elliott2, S.J. Bell2, S.J. Brown2, W.R. Connell2, P.V. Desmond2, S. Singh3

1University of Melbourne & St Vincent's Hospital, Department of Medicine, Melbourne, Australia, 2St Vincent's Hospital & University of Melbourne, Department of Gastroenterology, Melbourne, Australia, 3Prometheus Laboratories, Therapeutics & Diagnostics, San Diego, California, United States

P208.

Ileal wall thickness detected by MSCTE predicts the disease severity of Crohn's disease

Authors:

X. Yang, L. Yu, Z. Liu, Shanghai Tenth People's Hospital, Tongji University, Department of Gastroenterology, Shanghai, China

P208. Abnormal fibre utilisation and gut transit in ulcerative colitis in remission: A potential new target for dietary intervention
P208. Is availability of MR Enterography reducing avoidable use of ionising radiation in diagnostic imaging for Crohn's Disease?
Authors:

A. Smyth1, D. Gibson1, D. Murphy2, D. Keegan1, G. Cullen1, H. Mulcahy1, D. Malone2, G. Doherty1, 1St Vincent's University Hospital, Gastroenterology, Dublin, Ireland, 2St Vincent's University Hospital, Radiology, Dublin, Ireland

P208. Long-term colectomy rate in severe steroid-refractory ulcerative colitis treated with infliximab as rescue therapy
P208

Patient-reported outcomes in biologic and thiopurine treatment of IBD measured as HRQoL and symptoms

Authors:

S. Jäghult*, D. Andersson

Karolinska Institutet, Danderyd Hospital, Division of Medicine, Department of Clinical Sciences, Stockholm, Sweden

P209.

Influence of anxiety and depression in the clinical course of inflammatory bowel disease patients

Authors:

M. Barreiro-de Acosta, M. Iglesias, R. Ferreiro, A. Lorenzo, J.E. Dominguez-Muñoz, University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P209. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study
P209. In vivo molecular imaging using fluorescent anti-TNF antibodies and confocal laser endomicroscopy predicts response to anti-TNF therapy in Crohn's disease patients
Authors:

R. Atreya1, H. Neumann1, C. Neufert1, M.J. Waldner1, Y. Zopf1, M. Willma1, C. App2, T. Münster3, H. Kessler4, S. Maas5, B. Gebhardt5, R. Heimke-Brinck6, E. Reuter6, F. Dörje6, T.T. Rau7, T.D. Wang8, R. Kiesslich9, M. Vieth10, E. Hannappel2, M.F. Neurath1, 1Medical Clinic 1, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 2Department of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 3Department of Anesthesiology, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 4Department of Surgery, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 5Center for Clinical Studies, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 6Pharmacy Department, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 7Department of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, Germany, 8Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, United States, 9Medical Clinic, St. Mary's Hospital, Frankfurt, Germany, 10Institute of Pathology, Klinikum Bayreuth, Germany

P209. Thiopurine toxicity in patients with Crohn's disease: A study of genetic and clinical predictive factors
P209

Impact of perineal fistulization on behavior characteristics of intestinal crohn's disease

Authors:

N. Bounab*1, L. Kecili1, A. Balamane1, A. Bousseloub2, K. Belhocine1, K. Layaida1, N. Kaddache1, L. Gamar1, T. Boucekkine1, S. Berkane1

1CHU Mustapha, Faculty of Medicine, Algiers, Algeria, 2Hôpital Central de l'armée , Faculty of Medicine, Algiers, Algeria

P210.

IBD and HIV: Does CD4 count remission hypothesis count?

Authors:

A. Skamnelos1, A. Tatsioni2, K. Katsanos1, V. Tsianos1, D. Balomenos1, S. Liamas1, D. Christodoulou1, E. Tsianos1, 1University of Ioannina, Gastroenterology, Ioannina, Greece, 2Ioannina Medical School, Greece & Tufts University Medical School, Department of Internal Medicine, Ioannina, Greece

P210. Are combined medical and surgical treatments optimal therapy for complex perianal fistula in Crohn's disease?